Novartis Invests $280M in Denton Cancer Facility

Swiss pharmaceutical giant Novartis has officially begun construction on a $280 million advanced manufacturing facility in Denton, Texas, dedicated to producing next-generation cancer treatments. The groundbreaking ceremony marks a significant economic development win for the North Texas region, according to NBC 5 DFW coverage of the event. The state-of-the-art facility is expected to create hundreds of high-paying jobs in biotechnology and pharmaceutical manufacturing over the coming years. This major investment represents a growing trend of international healthcare companies establishing operations in Texas, bringing both employment opportunities and expanded access to cutting-edge medical treatments closer to communities throughout the Dallas-Fort Worth metroplex.

Source: NBC 5 DFW, Dallas

Leave a Comment